Logo
x

Search

Subscribe Now

astraZeneca

AstraZeneca’s Fasenra Receives NMPA’s Approval to Treat Severe Eosinophilic Asthma

AstraZeneca’s Fasenra Receives NMPA’s Approval to Treat Severe Eosinophilic Asthma

  • August 21, 2024
AstraZeneca's Imfinzi Gets the US FDA Priority Review and BTD for LS-SCLC

AstraZeneca's Imfinzi Gets the US FDA Priority Review and BTD for LS-SCLC

  • August 16, 2024
AstraZeneca’s Lynparza Plus Imfinzi Receives the EC’s Approval to Treat Endometrial Cancer

AstraZeneca’s Lynparza Plus Imfinzi Receives the EC’s Approval to Treat Endometrial Cancer

  • August 14, 2024
AstraZeneca and Daiichi Sankyo’s Enhertu Receives the NMPA’s Conditional Approval to Treat Gastric Cancer

AstraZeneca and Daiichi Sankyo’s Enhertu Receives the NMPA’s Conditional Approval to Treat Gastric Cancer

  • August 13, 2024
PharmaShots Weekly Snapshots (July 29 – August 02, 2024)

PharmaShots Weekly Snapshots (July 29 – August 02, 2024)

  • August 2, 2024
AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia

AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia

  • July 29, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.